Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)

Per Pfeiffer, Maryam Lustberg, Jacques Näsström, Stefan Carlsson, Anders Persson, Fumiko Nagahama, Guido Cavaletti, Bengt Glimelius, Kei Muro

Open source

DOI: 10.1093/jncics/pkac075
Published: 2022-10-29
Container: JNCI Cancer Spectrum
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jncics/pkac075,
  title = {Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)},
  author = {Per Pfeiffer and Maryam Lustberg and Jacques Näsström and Stefan Carlsson and Anders Persson and Fumiko Nagahama and Guido Cavaletti and Bengt Glimelius and Kei Muro},
  year = {2022},
  journal = {JNCI Cancer Spectrum},
  doi = {10.1093/jncics/pkac075},
  url = {https://doi.org/10.1093/jncics/pkac075}
}

RIS

TY  - JOUR
TI  - Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)
AU  - Per Pfeiffer
AU  - Maryam Lustberg
AU  - Jacques Näsström
AU  - Stefan Carlsson
AU  - Anders Persson
AU  - Fumiko Nagahama
AU  - Guido Cavaletti
AU  - Bengt Glimelius
AU  - Kei Muro
PY  - 2022
JO  - JNCI Cancer Spectrum
DO  - 10.1093/jncics/pkac075
UR  - https://doi.org/10.1093/jncics/pkac075
ER  -

APA

Pfeiffer, P., Lustberg, M., Näsström, J., Carlsson, S., Persson, A., Nagahama, F., Cavaletti, G., Glimelius, B., & Muro, K. (2022). Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M). JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkac075

Source records

crossref · retrieved 2026-09-26T14:51:58.495Z